The role of the automation development group in analytical research and development at Dupont Merck
1994

The Role of Robotics in Pharmaceutical Development

publication Evidence: moderate

Author Information

Author(s): John C. Lynch, Jonathan S. Green, Paul K. Hovsepian, Kathleen L. Reilly, Joseph A. Short

Primary Institution: The DuPont Merck Pharmaceutical Company

Hypothesis

Can automation improve productivity and efficiency in pharmaceutical research and development?

Conclusion

The integration of robotics in the laboratory has significantly enhanced productivity and method development in pharmaceutical research.

Supporting Evidence

  • Over 500 sample preparations were performed using the robotic system in a three-month period.
  • Three automated methods were developed and validated for use in regulatory filings.
  • Robotics helped improve the speed and accuracy of analyses in a regulated environment.

Takeaway

Using robots in labs helps scientists work faster and more accurately, making it easier to develop new medicines.

Methodology

The study involved the implementation of robotic systems to automate sample preparation and analysis in pharmaceutical development.

Potential Biases

Potential bias due to the reliance on specific robotic systems and vendor partnerships.

Limitations

The project faced challenges such as time constraints and the need for specialized training for staff.

Participant Demographics

The study involved a mid-sized pharmaceutical company with less than 100 employees in the analytical department.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication